# A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

> **NCT06209203** · PHASE2 · COMPLETED · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Corneal Epithelium Defect

## Interventions

- **DRUG:** lowe-dose ZKY001 eye drops
- **DRUG:** Medium-dose ZKY001 eye drops
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06209203
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-03
- **Primary completion:** 2022-11-08
- **Final completion:** 2022-11-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06209203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06209203, "A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06209203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*